Case Western Reserve University biomedical researchers develop first open-source, quality-control review tool for fast-growing digital pathology field There’s a low-tech problem troubling the ...

Powered by Guardant Infinity smart liquid biopsy platform, advanced multiomic test evaluates genomic, epigenomic and RNA-based molecular data First tissue comprehensive genomic profiling test to offer ...

Hospitalization Risk During Chemotherapy for Advanced Cancer: Development and Validation of Risk Stratification Models Using Real-World Data Digital pathology (DP), referring to the digitization of ...

GUARDANT HEALTH LAUNCHES GUARDANT360 TISSUE, FIRST TISSUE MOLECULAR PROFILING TEST WITH COMPREHENSIVE MULTIOMIC ANALYSIS TO PROVIDE A MORE COMPLETE VIEW OF CANCER Powered by Guardant Infinity smart ...

Moving beyond traditional methods of observing thinly sliced and stained cancer tissues, a collaborative international research team led by KAIST has successfully developed a new technology. This ...

"It acts like a digital second opinion, tirelessly checking virtually every stained tissue slide to ensure it is safe for diagnosis." Published in Nature Biomedical Engineering, AQuA operates ...

We combine advanced technologies such as spatial transcriptomics, multiplexed imaging, and in situ sequencing to map cellular components in their native tissue context. Obtain high-resolution data ...

Doctors and scientists have long relied on microscopes to study human tissue and diagnose disease. But today's medical ...